A citation-based method for searching scientific literature

Apostolos Klinakis, Dimitris Karagiannis, Theodoros Rampias. Cell Mol Life Sci 2020
Times Cited: 24







List of co-cited articles
80 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


State-of-the-art strategies for targeting the DNA damage response in cancer.
Patrick G Pilié, Chad Tang, Gordon B Mills, Timothy A Yap. Nat Rev Clin Oncol 2019
315
20

The multifaceted roles of PARP1 in DNA repair and chromatin remodelling.
Arnab Ray Chaudhuri, André Nussenzweig. Nat Rev Mol Cell Biol 2017
464
16

Targeting DNA Repair in Cancer: Beyond PARP Inhibitors.
Jessica S Brown, Brent O'Carrigan, Stephen P Jackson, Timothy A Yap. Cancer Discov 2017
267
16

ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.
Jianfeng Shen, Yang Peng, Leizhen Wei, Wei Zhang, Lin Yang, Li Lan, Prabodh Kapoor, Zhenlin Ju, Qianxing Mo, Ie-Ming Shih,[...]. Cancer Discov 2015
227
12

Genomic instability--an evolving hallmark of cancer.
Simona Negrini, Vassilis G Gorgoulis, Thanos D Halazonetis. Nat Rev Mol Cell Biol 2010
12


Non-canonical Activation of the DNA Sensing Adaptor STING by ATM and IFI16 Mediates NF-κB Signaling after Nuclear DNA Damage.
Gillian Dunphy, Sinéad M Flannery, Jessica F Almine, Dympna J Connolly, Christina Paulus, Kasper L Jønsson, Martin R Jakobsen, Michael M Nevels, Andrew G Bowie, Leonie Unterholzner. Mol Cell 2018
170
12

Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
Elizaveta E Alemasova, Olga I Lavrik. Nucleic Acids Res 2019
100
12

DNA double-strand break repair-pathway choice in somatic mammalian cells.
Ralph Scully, Arvind Panday, Rajula Elango, Nicholas A Willis. Nat Rev Mol Cell Biol 2019
303
12

The DNA damage response and cancer therapy.
Christopher J Lord, Alan Ashworth. Nature 2012
943
12

Mechanisms of DNA damage, repair, and mutagenesis.
Nimrat Chatterjee, Graham C Walker. Environ Mol Mutagen 2017
383
12

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
Helen E Bryant, Niklas Schultz, Huw D Thomas, Kayan M Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J Curtin, Thomas Helleday. Nature 2005
12

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
12

Targeting the DNA Damage Response in Cancer.
Mark J O'Connor. Mol Cell 2015
630
12

PARP inhibitors: Synthetic lethality in the clinic.
Christopher J Lord, Alan Ashworth. Science 2017
929
12

H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy.
Monika Podhorecka, Andrzej Skladanowski, Przemyslaw Bozko. J Nucleic Acids 2010
275
8

PARP1 Links CHD2-Mediated Chromatin Expansion and H3.3 Deposition to DNA Repair by Non-homologous End-Joining.
Martijn S Luijsterburg, Inge de Krijger, Wouter W Wiegant, Rashmi G Shah, Godelieve Smeenk, Anton J L de Groot, Alex Pines, Alfred C O Vertegaal, Jacqueline J L Jacobs, Girish M Shah,[...]. Mol Cell 2016
140
8

ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A.
Chris T Williamson, Rowan Miller, Helen N Pemberton, Samuel E Jones, James Campbell, Asha Konde, Nicholas Badham, Rumana Rafiq, Rachel Brough, Aditi Gulati,[...]. Nat Commun 2016
154
8

Novel function of the flap endonuclease 1 complex in processing stalled DNA replication forks.
Li Zheng, Mian Zhou, Qing Chai, Jay Parrish, Ding Xue, Steve M Patrick, John J Turchi, Steven M Yannone, David Chen, Binghui Shen. EMBO Rep 2005
110
8

BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer.
Sergey Karakashev, Hengrui Zhu, Yuhki Yokoyama, Bo Zhao, Nail Fatkhutdinov, Andrew V Kossenkov, Andrew J Wilson, Fiona Simpkins, David Speicher, Dineo Khabele,[...]. Cell Rep 2017
72
8

BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency.
Chaoyang Sun, Jun Yin, Yong Fang, Jian Chen, Kang Jin Jeong, Xiaohua Chen, Christopher P Vellano, Zhenlin Ju, Wei Zhao, Dong Zhang,[...]. Cancer Cell 2018
114
8

Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.
Cigall Kadoch, Diana C Hargreaves, Courtney Hodges, Laura Elias, Lena Ho, Jeff Ranish, Gerald R Crabtree. Nat Genet 2013
692
8

A nuclear poly(ADP-ribose)-dependent signalosome confers DNA damage-induced IkappaB kinase activation.
Michael Stilmann, Michael Hinz, Seda Cöl Arslan, Anja Zimmer, Valérie Schreiber, Claus Scheidereit. Mol Cell 2009
168
8

PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways.
Minli Wang, Weizhong Wu, Wenqi Wu, Bustanur Rosidi, Lihua Zhang, Huichen Wang, George Iliakis. Nucleic Acids Res 2006
522
8

DNA replication stress as a hallmark of cancer.
Morgane Macheret, Thanos D Halazonetis. Annu Rev Pathol 2015
337
8

DNA crosslinking damage and cancer - a tale of friend and foe.
Yaling Huang, Lei Li. Transl Cancer Res 2013
52
8


Timeline: Chemotherapy and the war on cancer.
Bruce A Chabner, Thomas G Roberts. Nat Rev Cancer 2005
934
8


Nucleotide excision repair in humans.
Graciela Spivak. DNA Repair (Amst) 2015
159
8

A brief history of the DNA repair field.
Errol C Friedberg. Cell Res 2008
45
8

Microhomology-mediated end joining is activated in irradiated human cells due to phosphorylation-dependent formation of the XRCC1 repair complex.
Arijit Dutta, Bradley Eckelmann, Sanjay Adhikari, Kazi Mokim Ahmed, Shiladitya Sengupta, Arvind Pandey, Pavana M Hegde, Miaw-Sheue Tsai, John A Tainer, Michael Weinfeld,[...]. Nucleic Acids Res 2017
43
8


Base excision repair.
Hans E Krokan, Magnar Bjørås. Cold Spring Harb Perspect Biol 2013
538
8


cGAS-STING, an important pathway in cancer immunotherapy.
Minlin Jiang, Peixin Chen, Lei Wang, Wei Li, Bin Chen, Yu Liu, Hao Wang, Sha Zhao, Lingyun Ye, Yayi He,[...]. J Hematol Oncol 2020
36
8

Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses Preclinically.
Lucy C Riches, Antonio G Trinidad, Gareth Hughes, Gemma N Jones, Adina M Hughes, Andrew G Thomason, Paul Gavine, Andy Cui, Stephanie Ling, Jonathan Stott,[...]. Mol Cancer Ther 2020
33
8

The DNA damage response arouses the immune system.
Stephan Gasser, David H Raulet. Cancer Res 2006
124
8


The cGAS Paradox: Contrasting Roles for cGAS-STING Pathway in Chromosomal Instability.
Christy Hong, Andrea E Tijhuis, Floris Foijer. Cells 2019
17
11

Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer.
Tzu-Ting Huang, Erika J Lampert, Cynthia Coots, Jung-Min Lee. Cancer Treat Rev 2020
27
8

AMPK and Autophagy.
Yanjun Li, Yingyu Chen. Adv Exp Med Biol 2019
60
8


Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
8

Structural basis of homologous recombination.
Yueru Sun, Thomas J McCorvie, Luke A Yates, Xiaodong Zhang. Cell Mol Life Sci 2020
28
8

Aberrations in DNA repair pathways in cancer and therapeutic significances.
Akira Motegi, Mitsuko Masutani, Ken-Ichi Yoshioka, Tadayoshi Bessho. Semin Cancer Biol 2019
29
8


DNA repair pathways as targets for cancer therapy.
Thomas Helleday, Eva Petermann, Cecilia Lundin, Ben Hodgson, Ricky A Sharma. Nat Rev Cancer 2008
8


Isolation of a small molecule inhibitor of DNA base excision repair.
Srinivasan Madhusudan, Fiona Smart, Paul Shrimpton, Jason L Parsons, Laurence Gardiner, Sue Houlbrook, Denis C Talbot, Timothy Hammonds, Paul A Freemont, Michael J E Sternberg,[...]. Nucleic Acids Res 2005
154
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.